These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1975275)

  • 21. Differential regulation of sigma and PCP receptors after chronic administration of haloperidol and phencyclidine in mice.
    Itzhak Y; Alerhand S
    FASEB J; 1989 May; 3(7):1868-72. PubMed ID: 2541039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/sigma-receptor.
    Sircar R; Rappaport M; Nichtenhauser R; Zukin SR
    Brain Res; 1987 Dec; 435(1-2):235-40. PubMed ID: 2827853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneous binding of sigma radioligands in the rat brain and liver: possible relationship to subforms of cytochrome P-450.
    Ross SB
    Pharmacol Toxicol; 1991 Apr; 68(4):293-301. PubMed ID: 1650944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiplicity of [3H]1,3-di-o-tolylguanidine binding sites with low affinity for haloperidol in rat brain.
    Enomoto R; Ogita K; Yoneda Y
    Biol Pharm Bull; 1993 Oct; 16(10):989-96. PubMed ID: 8287051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological specificity of some psychotomimetic and antipsychotic agents for the sigma and PCP binding sites.
    Itzhak Y
    Life Sci; 1988; 42(7):745-52. PubMed ID: 2893238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiosynthesis of sigma receptor ligands for positron emission tomography: 11C- and 18F-labeled guanidines.
    Wilson AA; Dannals RF; Ravert HT; Sonders MS; Weber E; Wagner HN
    J Med Chem; 1991 Jun; 34(6):1867-70. PubMed ID: 1648140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of sigma-receptors: high- and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-Di(2-tolyl)guanidine.
    Beart PM; O'Shea RD; Manallack DT
    J Neurochem; 1989 Sep; 53(3):779-88. PubMed ID: 2569504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
    Brent PJ
    Brain Res; 1996 Jul; 725(2):155-65. PubMed ID: 8836521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Competitive interactions at [3H]1,3-di(2-tolyl)guanidine (DTG)-defined sigma recognition sites in guinea pig brain.
    DeHaven-Hudkins DL; Fleissner LC
    Life Sci; 1992; 50(9):PL65-70. PubMed ID: 1346920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of specific binding sites for [3H]-1,3-di-o-tolyl-guanidine (DTG) in the rat glioma cell line C6-BU-1.
    Georg A; Friedl A
    Glia; 1992; 6(4):258-63. PubMed ID: 1464457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor binding profiles of KB-5492, a novel anti-ulcer agent, at sigma receptors in guinea-pig brain.
    Harada Y; Hara H; Sukamoto T
    Eur J Pharmacol; 1994 May; 256(3):321-8. PubMed ID: 8045277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naloxone-sensitive, haloperidol-sensitive, [3H](+)SKF-10047-binding protein partially purified from rat liver and rat brain membranes: an opioid/sigma receptor?
    Tsao LI; Su TP
    Synapse; 1997 Feb; 25(2):117-24. PubMed ID: 9021892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple vascular effects of sigma and PCP ligands: inhibition of amine uptake and contractile responses.
    Massamiri T; Duckles SP
    J Pharmacol Exp Ther; 1990 Apr; 253(1):124-9. PubMed ID: 2158542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
    Monnet FP; de Costa BR; Bowen WD
    Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiosynthesis, cerebral distribution, and binding of [125I]-1-(p-iodophenyl)-3-(1-adamantyl)guanidine, a ligand for sigma binding sites.
    Kimes AS; Wilson AA; Scheffel U; Campbell BG; London ED
    J Med Chem; 1992 Dec; 35(25):4683-9. PubMed ID: 1469697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
    Rothman RB; Reid A; Mahboubi A; Kim CH; De Costa BR; Jacobson AE; Rice KC
    Mol Pharmacol; 1991 Feb; 39(2):222-32. PubMed ID: 1847495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel (4-phenylpiperidinyl)- and (4-phenylpiperazinyl)alkyl-spaced esters of 1-phenylcyclopentanecarboxylic acids as potent sigma-selective compounds.
    Hudkins RL; Mailman RB; DeHaven-Hudkins DL
    J Med Chem; 1994 Jun; 37(13):1964-70. PubMed ID: 8027978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brain.
    Bonhaus DW; Loury DN; Jakeman LB; Hsu SA; To ZP; Leung E; Zeitung KD; Eglen RM; Wong EH
    J Pharmacol Exp Ther; 1994 Oct; 271(1):484-93. PubMed ID: 7965749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and characterization of an affinity label for brain receptors to psychotomimetic benzomorphans: differentiation of sigma-type and phencyclidine receptors.
    Adams JT; Teal PM; Sonders MS; Tester B; Esherick JS; Scherz MW; Keana JF; Weber E
    Eur J Pharmacol; 1987 Oct; 142(1):61-71. PubMed ID: 2826177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of 1,3-di(2-[5-3H]tolyl) guanidine with sigma 2 binding sites in rat heart membrane preparations.
    Dumont M; Lemaire S
    Eur J Pharmacol; 1991 Dec; 209(3):245-8. PubMed ID: 1665796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.